Results 241 to 250 of about 10,333,992 (256)

Good or Bad: Paradox of Plasminogen Activator Inhibitor 1 (PAI-1) in Digestive System Tumors

Cancer Letters, 2023
Baohong Gu, Puyi He, Jingyu Zhu
exaly  

Experimental Approaches Toward Histone Acetyltransferase Modulators as Therapeutics

Medical Epigenetics, 2021
exaly  

Immune Checkpoint Inhibitors May Be Safe for Patients With Preexisting Autoimmune Disease

Ca-A Cancer Journal for Clinicians, 2020
Mike Fillon
exaly  

Promoter (4G/5G) Plasminogen Activator Inhibitor-1 Genotype and Plasminogen Activator Inhibitor-1 Levels in Blacks, Hispanics, and Non-Hispanic Whites

Circulation, 2003
Russell P Tracy, Ralph B. D'Agostino Jr, Stephen S Rich   +2 more
exaly  

NAD+-Dependent Deacetylases and Medical Therapy

Medical Epigenetics, 2016
M Dvir-Ginzberg
exaly  

Pattern Formation and Turing Instability in an Activator–Inhibitor System With Power-Law Coupling

Physica A: Statistical Mechanics and Its Applications, 2015
R L Viana, S R Lopes
exaly  

Pharmacoepigenomics

Medical Epigenetics, 2016
exaly  

Expression of the Plasminogen Activator System and the Inhibitors PAI-1 and PAI-2 in Posttraumatic Lesions of the CNS and Brain Injuries Following Dramatic Circulatory Arrests: An Immunohistochemical Study

Pathology Research and Practice, 2000
Holger Wittig, E Kirches, D Krause
exaly  

Histone Deacetylase Inhibitors in Medical Therapeutics

Medical Epigenetics, 2016
exaly  

Placental-Type Plasminogen Activator Inhibitor in Preeclampsia

American Journal of Obstetrics and Gynecology, 1988
Ingegerd Lecander, I Lecander, Jan W Ten Cate   +2 more
exaly